Kinase mutant Btk results in atypical X-linked agammaglobulinaemia phenotype

Clinical and Experimental Immunology

Volumn 120, Issue 2, 2000, Pages 346-350

  Gaspar, H B ^a   Ferrando, M ^b   Caragol, I ^b   Hernandez, M ^b   Bertran, J M ^b   De Gracia, X ^b   Lester, T ^c   Kinnon, C ^a   Ashton, E ^a   Espanol, T ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Regional Molecular Genetics Laboratory   (United Kingdom)

Author keywords

Atypical XLA; Bruton's tyrosine kinase; Kinase domain; X linked agammaglobulinaemia

Indexed keywords

IMMUNOGLOBULIN; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; AUTOPHOSPHORYLATION; CASE REPORT; ENZYME STRUCTURE; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; X LINKED AGAMMAGLOBULINEMIA;

ADULT; AGAMMAGLOBULINEMIA; DNA MUTATIONAL ANALYSIS; HUMANS; IMMUNOPHENOTYPING; INFANT; MALE; POINT MUTATION; PROTEIN-TYROSINE KINASES; X CHROMOSOME;

EID: 0034125410     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01230.x     Document Type: Article

References (32)

1. 1 Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993; 72:279-90.
2. 2 Vetrie D, Vorechovsky I, Sideras P et al. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 1993; 361:226-33.
3. 3 Mano H, Yamashita Y, Sato K, Yazaki Y, Hirai H. Tec protein-tyrosine kinase is involved in interleukin-3 signaling pathway. Blood 1995; 85:343-50.
4. 4 Tamagnone L, Lahtinen I, Mustonen T et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 1994; 9:3683-8.
5. 5 Heyeck SD, Berg LJ. Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci USA 1993; 90:669-73.
6. 6 Mattsson PT, Vihinen M, Smith CI. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. Bioessays 1996; 18:825-34.
7. 7 Matsuda T, Fukada T, Takahashi Tezuka M et al. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association. J Biol Chem 1995; 270:11037-9.
8. 8 Sato S, Katagiri T, Takaki S et al. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases. J Exp Med 1994; 180:2101-11.
9. 9 Kawakami Y, Yao L, Miura T, Tsukada S, Witte ON, Kawakami T. Tyrosine phosphorylation and activation of Bruton tyrosine kinase upon Fc epsilon RI cross-linking. Mol Cell Biol 1994; 14:5108-13.
10. 10 Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 1998; 8:509-16.
11. 11 Fluckiger AC, Li Z, Kato RM et al. Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J 1998; 17:1973-85.
12. 12 Scharenberg AM, EI HO, Fruman DA et al. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998; 17:1961-72.
13. 13 Wahl MI, Fluckiger AC, Kato RM, Park H, Witte ON, Rawlings DJ. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors. Proc Natl Acad Sci USA 1997; 94:11526-33.
14. 14 Rawlings DJ, Scharenberg AM, Park H et al. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 1996; 271:822-5.
15. 15 Vihinen M, Brandau O, Branden LJ et al. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucl Acids Res 1998; 26:242-7.
16. 16 Jones A, Bradley L, Alterman L et al. X linked agammaglobulinaemia with a 'leaky' phenotype. Arch Dis Child 1996; 74:548-9.
17. 17 Hashimoto S, Tsukada S, Matsushita M et al. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 1996; 88:561-73.
18. 18 Kornfeld SJ, Haire RN, Strong SJ et al. Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family. J Allergy Clin Immunol 1997; 100:702-6.
19. 19 Gaspar HB, Lester T, Levinsky RJ, Kinnon C. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Clin Exp Immunol 1998; 111:334-8.
20. 20 Futatani T, Miyawaki T, Tsukada S et al. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998; 91:595-602.
21. 21 Vorechovsky I. SSCP at the BTK locus. Hum Mol Genet 1994; 3:1031.
22. 22 Hagemann TL, Chen Y, Rosen FS, Kwan SP. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hum Mol Genet 1994; 3:1743-9.
23. 23 Conley ME, Fitch Hilgenberg ME, Cleveland JL, Parolini O, Rohrer J. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Hum Mol Genet 1994; 3:1751-6.
24. 24 Staugas RE, Beard LJ, Simmer K, Ferrante A. Hypogammaglobulinemia and depressed natural killer cell cytotoxicity in a patient with Pneumocystis carinii infection. Pediatr Infect Dis J 1988; 7:724-8.
25. 25 Rao CP, Gelfand EW. Pneumocystis carinii pneumonitis in patients with hypogammaglobulinemia and intact T cell immunity. J Pediatr 1983; 103:410-2.
26. 26 Alibrahim A, Lepore M, Lierl M, Filipovich A, Assaad A. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. J Allergy Clin Immunol 1998; 101:552-3.
27. 27 Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Med Baltimore 1985; 64:145-56.
28. 28 Bonagura VR, Cunningham RS, Edwards BL, Ilowite NT, Wedgwood JF, Valacer DJ. Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous gamma-globulin therapy, and natural killer deficiency. Clin Immunol Immunopathol 1989; 51:216-31.
29. 29 Kornfeld SJ, Haire RN, Strong SJ et al. A novel mutation (Cys145→↖ Stop) in Bruton's tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Mol Med 1996; 2:619-23.
30. 30 Vihinen M, Vetrie D, Maniar HS et al. Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease. Proc Natl Acad Sci USA 1994; 91:12803-7.
31. 31 Zhu Q. Zhang M, Winkelstein J, Chen SH, Ochs HD. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families. Hum Mol Genet 1994; 3:1899-900.
32. 32 Yang W, Desiderio S. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci USA 1997; 94:604-9.